Cargando…
Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images.
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380081/ https://www.ncbi.nlm.nih.gov/pubmed/34457284 http://dx.doi.org/10.1002/ccr3.4604 |
_version_ | 1783741125063868416 |
---|---|
author | Gatto, Lidia Franceschi, Enrico Tosoni, Alicia Di Nunno, Vincenzo Maggio, Ilaria Tonon, Caterina Lodi, Raffaele Agati, Raffaele Bartolini, Stefania Brandes, Alba Ariela |
author_facet | Gatto, Lidia Franceschi, Enrico Tosoni, Alicia Di Nunno, Vincenzo Maggio, Ilaria Tonon, Caterina Lodi, Raffaele Agati, Raffaele Bartolini, Stefania Brandes, Alba Ariela |
author_sort | Gatto, Lidia |
collection | PubMed |
description | Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images. |
format | Online Article Text |
id | pubmed-8380081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83800812021-08-27 Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review Gatto, Lidia Franceschi, Enrico Tosoni, Alicia Di Nunno, Vincenzo Maggio, Ilaria Tonon, Caterina Lodi, Raffaele Agati, Raffaele Bartolini, Stefania Brandes, Alba Ariela Clin Case Rep Case Reports Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images. John Wiley and Sons Inc. 2021-08-21 /pmc/articles/PMC8380081/ /pubmed/34457284 http://dx.doi.org/10.1002/ccr3.4604 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Gatto, Lidia Franceschi, Enrico Tosoni, Alicia Di Nunno, Vincenzo Maggio, Ilaria Tonon, Caterina Lodi, Raffaele Agati, Raffaele Bartolini, Stefania Brandes, Alba Ariela Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review |
title | Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review |
title_full | Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review |
title_fullStr | Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review |
title_full_unstemmed | Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review |
title_short | Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review |
title_sort | distinct mri pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: case report and literature review |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380081/ https://www.ncbi.nlm.nih.gov/pubmed/34457284 http://dx.doi.org/10.1002/ccr3.4604 |
work_keys_str_mv | AT gattolidia distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview AT franceschienrico distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview AT tosonialicia distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview AT dinunnovincenzo distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview AT maggioilaria distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview AT tononcaterina distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview AT lodiraffaele distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview AT agatiraffaele distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview AT bartolinistefania distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview AT brandesalbaariela distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview |